In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder

Journal of Autism and Developmental Disorders

Volumn 44, Issue 10, 2014, Pages 2558-2567

  Gidaya, Nicole B ^a   Lee, Brian K ^a   Burstyn, Igor ^a   Yudell, Michael ^a   Mortensen, Erik L ^b   Newschaffer, Craig J ^a  

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Autism spectrum disorders; Depression; Pregnancy; Selective serotonin reuptake inhibitors

Indexed keywords

PRESCRIPTION DRUG; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; AUTISM; CHILD; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PATERNAL AGE; PREGNANCY; PRENATAL EXPOSURE; PUERPERAL DEPRESSION; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SOCIAL STATUS; THIRD TRIMESTER PREGNANCY; TREATMENT INDICATION; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DENMARK; DEPRESSION; MIDDLE AGED; REGISTER; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DENMARK; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84912027605     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-014-2128-4     Document Type: Article

References (58)

1. Anderson, G. M., Czarkowski, K., Ravski, N., & Epperson, C. N. (2004). Platelet serotonin in newborns and infants: Ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors. Pediatric Research, 56, 418–422.
2. Anderson, G. M., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900.
3. Andrade, S. E., et al. (2008). Use of antidepressant medications during pregnancy: A multisite study. American Journal of Obstetrics and Gynecology, 198(194), e1–e5.
4. Atladottir, H. O., et al. (2009). Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 124, 687–694.
5. Atladottir, H. O., et al. (2010). Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. Journal of Autism and Developmental Disorders, 40, 1423–1430.
6. Bakker, M. K., Kerstjens-Frederikse, W. S., Buys, C. H., de Walle, H. E., & de Jong-van den Berg, L. T. (2010). First-trimester use of paroxetine and congenital heart defects: A population-based case–control study. Birth Defects Research Part A: Clinical and Molecular Teratology, 88, 94–100.
7. Bakker, M.K., Kolling, P., van den Berg, P. B., de Walle, H. E., & de Jong-van den Berg, L.T. (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology, 65, 600–606.
8. Bodnar, L. M., Siega-Riz, A. M., Simhan, H. N., Diesel, J. C., & Abrams, B. (2010). The impact of exposure misclassification on associations between prepregnancy BMI and adverse pregnancy outcomes. Obesity (Silver Spring), 18, 2184–2190.
9. Bolton, P. F., Pickles, A., Murphy, M., & Rutter, M. (1998). Autism, affective and other psychiatric disorders: Patterns of familial aggregation. Psychological Medicine, 28, 385–395.
10. Bonnin, A., & Levitt, P. (2011). Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience, 197, 1–7.
11. Borue, X., Chen, J., & Condron, B. G. (2007). Developmental effects of SSRIs: Lessons learned from animal studies. International Journal of Developmental Neuroscience, 25, 341–347.
12. Brennan, P. A., Hammen, C., Andersen, M. J., Bor, W., Najman, J. M., & Williams, G. M. (2000). Chronicity, severity, and timing of maternal depressive symptoms: Relationships with child outcomes at age 5. Developmental Psychology, 36, 759–766.
13. Burstyn, I., Sithole, F., & Zwaigenbaum, L. (2010). Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Diseases in Canada, 30, 125–134.
14. Caplan, H. L., Cogill, S. R., Alexandra, H., Robson, K. M., Katz, R., & Kumar, R. (1989). Maternal depression and the emotional development of the child. British Journal of Psychiatry, 154, 818–822.
15. Carter, A. S., Garrity-Rokous, F. E., Chazan-Cohen, R., Little, C., & Briggs-Gowan, M.J. (2001). Maternal depression and comorbidity: Predicting early parenting, attachment security, and toddler social– emotional problems and competencies. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 18–26.
16. Cook, E. H, Jr, Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488–491.
17. Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology, 196(544), e1–e5.
18. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68, 1104–1112.
19. Daniels, J. L., et al. (2008). Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics, 121, e1357–e1362.
20. Deave, T., Heron, J., Evans, J., & Emond, A. (2008). The impact of maternal depression in pregnancy on early child development. BJOG, 115, 1043–1051.
21. Durkin, M. S., et al. (2010). Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a US cross-sectional study. PLoS One, 5, e11551.
22. Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001). Cohort study of depressed mood during pregnancy and after childbirth. BMJ, 323, 257–260.
23. Frisell, T., Oberg, S., Kuja-Halkola, R., & Sjolander, A. (2012). Sibling comparison designs: Bias from non-shared confounders and measurement error. Epidemiology, 23, 713–720.
24. Giarelli, E., et al. (2010). Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disability and Health Journal, 3, 107–116.
25. Gislason, G. H., et al. (2006). Long-term compliance with betablockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. European Heart Journal, 27, 1153–1158.
26. Hanley, J. A. (2001). A heuristic approach to the formulas for population attributable fraction. Journal of Epidemiology and Community Health, 55, 508–514.
27. Hanley, G. E., Brain, U., & Oberlander, T. F. (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human Development, 89, 519–524.
28. Huot, R. L., Brennan, P. A., Stowe, Z. N., Plotsky, P. M., & Walker, E. F. (2004). Negative affect in offspring of depressed mothers is predicted by infant cortisol levels at 6 months and maternal depression during pregnancy, but not postpartum. Annals of the New York Academy of Sciences, 1032, 234–236.
29. Hviid, A., Melbye, M., & Pasternak, B. (2013). Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New England Journal of Medicine, 369, 2406–2415.
30. Jimenez-Solem, E., et al. (2012). Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: A nationwide cohort study. BMJ Open, 2, 1–9.
31. Jimenez-Solem, E., et al. (2013). SSRI use during pregnancy and risk of stillbirth and neonatal mortality. American Journal of Psychiatry, 170, 299–304.
32. Jones, W., & Klin, A. (2009). Heterogeneity and homogeneity across the autism spectrum: The role of development. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 471–473.
33. Josefsson, A., Berg, G., Nordin, C., & Sydsjo, G. (2001). Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstetricia et Gynecologica Scandinavica, 80, 251–255.
34. Kaae, J., Boyd, H. A., Hansen, A. V., Wulf, H. C., Wohlfahrt, J., & Melbye, M. (2010). Photosensitizing medication use and risk of skin cancer. Cancer Epidemiology Biomarkers & Prevention, 19, 2942–2949.
35. Kanner, L. (1968). Autistic disturbances of affective contact. Acta Paedopsychiatr, 35, 100–136.
36. Kieler, H., et al. (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. BMJ, 344, d8012.
37. Lam, K. S., Aman, M. G., & Arnold, L. E. (2006). Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 27, 254–289.
38. Larsson, H. J., et al. (2005). Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161, 916–925. (discussion 926–8).
39. Lauritsen, M. B., et al. (2010). Validity of childhood autism in the Danish Psychiatric Central Register: Findings from a cohort sample born 1990–1999. Journal of Autism and Developmental Disorders, 40, 139–148.
40. Lee, D., Majumdar, S. R., Lipton, H. L., Soumerai, S. B., Hennessy, S., & Davis, R. L. (2013). Special applications of pharmacoepidemiology. In B. L. Strom & S. E. Kimmel (Eds.), Textbook of pharmacoepidemiology (pp. 399–445). Philadelphia: Wiley.
41. Lin, D. Y., Psaty, B. M., & Kronmal, R. A. (1998). Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics, 54, 948–963.
42. Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010). Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology, 21, 383–388.
43. Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009). Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Archives of Pediatrics and Adolescent Medicine, 163, 949–954.
44. Maciag, D., et al. (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology, 31, 47–57.
45. Moth, G., Schiotz, P. O., & Vedsted, P. (2008). A Danish populationbased cohort study of newly diagnosed asthmatic children’s care pathway: Adherence to guidelines. BMC Health Services Research, 8, 130.
46. Olesen, C., Thrane, N., Nielsen, G. L., Sorensen, H. T., & Olsen, J. (2001). A population-based prescription study of asthma drugs during pregnancy: Changing the intensity of asthma therapy and perinatal outcomes. Respiration, 68, 256–261.
47. Olsen, L. R., Mortensen, E. L., & Bech, P. (2004). Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatrica Scandinavica, 109, 96–103.
48. Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case–control study. BMJ, 346, f2059.
49. Ramos, E., St-Andre, M., Rey, E., Oraichi, D., & Berard, A. (2008). Duration of antidepressant use during pregnancy and risk of major congenital malformations. British Journal of Psychiatry, 192, 344–350.
50. Rice, F., Jones, I., & Thapar, A. (2007). The impact of gestational stress and prenatal growth on emotional problems in offspring: A review. Acta Psychiatrica Scandinavica, 115, 171–183.
51. Schendel, D., & Bhasin, T. K. (2008). Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics, 121, 1155–1164.
52. Schernhammer, E., Hansen, J., Rugbjerg, K., Wermuth, L., & Ritz, B. (2011). Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care, 34, 1102–1108.
53. Sorensen, M. J., et al. (2013). Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clinical Epidemiology, 5, 449–459.
54. Susser, E., Eide, M. G., & Begg, M. (2010). Invited commentary: The use of sibship studies to detect familial confounding. American Journal of Epidemiology, 172, 537–539.
55. Vorhees, C. V., Acuff-Smith, K. D., Schilling, M. A., Fisher, J. E., Moran, M. S., & Buelke-Sam, J. (1994). A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundamental and Applied Toxicology, 23, 194–205.
56. Weikum, W. M., Oberlander, T. F., Hensch, T. K., & Werker, J. F. (2012). Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proceedings of the National Academy of Sciences of the USA, 109(Suppl 2), 17221–17227.
57. Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485.
58. Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. (2013). Priorities for autism spectrum disorders risk communication and ethics. Autism, 17(6), 701–722.